HYPERION DEFI, INC. Convertible Preferred Stock, Shares Issued upon Conversion
HYPERION DEFI, INC. (HYPD) had Convertible Preferred Stock, Shares Issued upon Conversion of 4.70 million shares as of 2018-01-29, per its 10-K filed 2020-03-30.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2020-03-30
- 2018-01-29: Convertible Preferred Stock, Shares Issued upon Conversion 4.70M shares; Convertible Preferred Stock, Shares Issued upon Conversion as first filed 4.64M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion | Convertible Preferred Stock, Shares Issued upon Conversion as first filed |
|---|---|---|
| 2018-01-29 | 4.70M shares 10-K · filed 2020-03-30 | 4.64M shares 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |